Modelling the impact and cost-effectiveness of novel approaches for TB control in Nunavut

对努纳武特地区结核病控制新方法的影响和成本效益进行建模

• 批准号: 402903
• 负责人: Zwerling Alice A
• 金额: $ 12.82万
• 依托单位: University of Ottawa
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-03-01 至 2021-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=402903&lang=en
• 关键词: Cost-Effectiveness Analysis; Modelling Population Level Impact; Tuberculosis Among Inuit; Tuberculosis Community Wide Screening Programs; Tuberculosis Elimination Among Inuit

Rates of Tuberculosis (TB) among the Inuit are up to 296 times higher than the Canadian, leading to significantly higher number of cases of disease and morbidity. TB is curable, but providing specialized health care in remote northern communities poses ma

因纽特人的结核病 (TB) 发病率比加拿大人高出 296 倍，导致疾病病例数和发病率显着增加。结核病是可以治愈的，但在偏远的北部社区提供专门的医疗保健仍是一个难题